Lily Ai Vee Chua is a researcher affiliated with the Epidemiology and Disease Control Division at the Ministry of Health in Singapore. Her work primarily focuses on epidemiological studies, particularly in the areas of infectious diseases and public health surveillance. Her research contributes to understanding and managing health challenges in Singapore, especially concerning vaccine-preventable diseases and influenza.
Research Contributions
Lily Ai Vee Chua has made significant contributions to the field of epidemiology, particularly in understanding infectious diseases and their impact on public health in Singapore. Her research includes a study on the decline of Guillain-Barré syndrome during the COVID-19 pandemic, highlighting potential changes in disease patterns during global health crises. She has also investigated the seroprevalence of vaccine-preventable diseases among children and adolescents, providing critical insights into vaccination coverage and immunity levels. Moreover, her work on evaluating influenza vaccine effectiveness and estimating influenza-associated hospitalizations has been vital in assessing the burden of influenza in tropical climates. Additionally, she has contributed to developing accurate estimates for the HIV care cascade in Singapore, utilizing a national HIV registry to enhance understanding and management of HIV.
Aliases
Lily Ai Vee Chua is also known by her aliases Lily Chua and L. Chua. These variations of her name appear in different publications and academic records.
